SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-016052
Filing Date
2024-06-07
Accepted
2024-06-07 18:00:05
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 form4-06072024_060601.html 4  
1 form4-06072024_060601.xml 4 4097
  Complete submission text file 0001415889-24-016052.txt   5568
Mailing Address C/O INSULET CORPORATION 600 TECHNOLOGY PARK DRIVE, SUITE 200 BILLERICA MA 01821
Business Address
Dorval Allison (Reporting) CIK: 0001625110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 241030933

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)